Table 2.
Dose levels, treatment duration, and outcomes.
| INITIAL DOSE OF REGORAFENIB, MG/DAY | n (%) |
|---|---|
| 160 | 10 (34) |
| 120 | 17 (59) |
| 80 | 2 (7) |
| Dose modifications, n (%) | 15 (51) |
| Dose reductions, n (%) | 9 (31) |
| Median duration of treatment, months (range) | 2.5 (0,13–11,4) |
| Reasons for stop, n (%) | |
| Progression | 23 (79) |
| Toxicity | 6 (21) |
| Best response n* (%) | |
| Stable disease | 7 (24) |
| Progression disease | 20 (69) |
Note:
Missing data.